abstract |
The present invention relates to a tetrahydropyrazolopyrimidine compound. Embodiments of the present disclosure provide tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and / or 8, and pharmaceuticals effective in the treatment of systemic lupus erythematosus (SLE) and lupus nephritis Relates to its use in the composition. [Selection figure] None |